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Abstract
Video- encephalographic (vEEG) seizure recordings make essential contributions 
to the differentiation of epilepsy and psychogenic nonepileptic seizures (PNES). 
The yield of vEEG examinations can be increased through suggestive seizure 
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1 |  INTRODUCTION
Psychogenic nonepileptic seizures (PNES) are a common 
problem in neurological practice, with an estimated preva-
lence of 50/100 000.1 The process leading to the diagnosis 
of PNES is often complex.2 The majority of patients are ini-
tially diagnosed with epilepsy, and the correct diagnosis of 
PNES can be delayed by several years.3 Twenty to 40 per-
cent of patients admitted to tertiary centers turn out to have 
PNES rather than drug- resistant epilepsy.4 The inappropri-
ate prescription of antiseizure medications (ASMs) to pa-
tients with PNES erroneously diagnosed with epilepsy over 
long periods of time is associated with a high risk of iatro-
genic harm (including death), and the provision of medical 
and social care to patients with PNES generates substan-
tial costs to individuals, families, and society at large.5,6 
Delays in correct diagnosis also mean that appropriate and 
evidence- based treatment of PNES is often delayed.
The confirmation of the diagnosis is the first step toward ap-
propriate management (ie, stopping inappropriately prescribed 
manipulation (SSM) (ie, activation/provocation/cessation procedures), but its use has 
raised ethical concerns. In preparation for guidelines on the investigation of patients 
with PNES, the ILAE PNES Task Force carried out an international survey to inves-
tigate practices of and opinions about SSM. An online questionnaire was developed 
by the ILAE PNES Task Force. Questions were asked at clinical unit or individual 
respondent level. All ILAE chapters were encouraged to send questionnaires to their 
members. The survey was open from July 1, 2019, to August 31, 2019. A total of 
487 clinicians from 411 units across 94 countries responded. Some form of SSM 
was used in 296/411 units (72.0%). Over 90% reported the use of verbal suggestion, 
over 80% the use of activation procedures also capable of eliciting epileptic activity 
(hyperventilation or photic stimulation). Only 26.3% of units used techniques specifi-
cally intended to provoke PNES (eg, saline injection). Fewer than 10% of units had 
established protocols for SSM, only 20% of units required written patient consent, 
in 12.2% of units patients received explicitly false information to provoke seizures. 
Clinicians using SSM tended to perceive no ethical problems, whereas those not using 
SSM were likely to have ethical concerns about these methods. We conclude that the 
use of invasive nocebo techniques intended to provoke PNES in diagnostic settings 
has declined, but SSM is commonly combined with activation procedures also capa-
ble of eliciting epileptic activity. While research suggests that openness about the use 
of PNES- specific nocebo techniques does not reduce diagnostic yield, very few units 
have suggestion protocols or seek patient consent. This could be addressed through 
establishing consensus guidance for the practice of SSM.
K E Y W O R D S
Psychogenic nonepileptic seizures (PNES), dissociative seizures, provocation methods, activation 
procedures, electroencephalography, suggestion, diagnosis
Key points
• Use of suggestive seizure manipulation (SSM) 
in diagnosing psychogenic nonepileptic seizures 
(PNES) has raised ethical concerns
• This survey describes current practice in and at-
titudes toward SSM in the diagnosis of PNES 
across 411 clinical practices in 94 countries
• SSM was used in 72% of units. Fewer than 10% of 
units had established protocols for SSM and only 
20% required written patient consent
• Clinicians using SSM tended to perceive no ethi-
cal problems, whereas those not using SSM were 
likely to have ethical concerns
• This ILAE survey underscores the need for a 
standardized approach to the use of SSM in the 
diagnosis of PNES
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ASMs and offering psychotherapeutic care). Correct diagnosis 
provides the basis for an effective delivery of an explanation of 
the condition to patient and family, which can be considered as 
a therapeutic intervention in itself7 and which has been shown 
to lead to the cessation of PNES in at least one in six patients.8
The Psychogenic Nonepileptic Seizures Task Force of the 
International League Against Epilepsy (ILAE) delineated a 
staged approach to PNES diagnosis.9 Although descriptions 
of seizure manifestations by patients and witnesses make a 
very important contribution to the diagnosis of PNES, the 
highest level of diagnostic certainty can only be reached 
through the simultaneous video- and EEG- recording of a 
typical seizure event.9– 12
In view of the diagnostic gain the recording of a typical 
PNES can achieve, clinicians have attempted to increase the 
yield of EEG or video- EEG (vEEG) recordings by using sug-
gestive seizure manipulation (induction and cessation) (SSM) 
methods, also known as seizure provocation techniques.13 For 
the purposes of this paper, the term SSM includes any pro-
cedure used to make the occurrence of a PNES more likely, 
ranging from simple verbal suggestion to the intravenous in-
jection of placebo. Commonly reported SSM methods also 
include conventional EEG activation procedures like hyper-
ventilation, intermittent photic stimulation, temporal com-
pression, or a combination of these techniques.14
The use of suggestion as a diagnostic method in this 
context dates at least as far back as Jean- Martin Charcot and 
the Salpêtrière School in Paris, France, during the 1880s. In 
his clinical lessons that attracted large audiences, Charcot 
used a range of provocation methods, including hypnosis 
to trigger “hystero- epilepsy.”15 Charcot also encouraged ef-
forts to capture the visible seizure semiology in drawings 
and photographs.16 The role of the EEG in the distinction 
of epileptic and nonepileptic seizures was recognized soon 
after the initial description of this physiological measure 
by Berger in 1929.17 The importance of filming of seizures 
for diagnostic and research purposes was highlighted by 
Loewenstein in 1933, and in 1945, Herbert Kupper first 
described the use of SSM for PNES diagnosis during an 
EEG- recording.18
Although it is not possible to report a mean additional di-
agnostic yield rate achieved by SSM techniques in view of 
the heterogeneity of patient selection and SSM methods in 
the primary research, more recent studies have confirmed the 
potential of SSM to be associated with improvements in the 
diagnostic yield of time- limited (v)EEG recordings in pa-
tients with suspected PNES in both inpatient and outpatient 
settings. This research has been summarized recently in a 
systematic review.14 SSM methods have, however, increas-
ingly been subject to controversy regarding their clinical rel-
evance, acceptability to patients, ethical issues, and potential 
impact on the doctor- patient relationship.19,20 Nevertheless, 
relatively recent surveys confirmed the widespread use of 
SSM techniques. For instance, two surveys conducted in 
the United States in 1996 revealed that 40% of neurologists 
routinely used SSM21 and that SSM was used in 73% of ep-
ilepsy centers.22 We are not aware of any previous studies 
examining the worldwide use of SSM in this clinical context, 
but publications from many countries demonstrate that these 
techniques have been used more recently and not only in the 
United States.14
In preparation for future ILAE guidance on diagnostic 
procedures for suspected PNES and in close collaboration 
with the ILAE PNES Task Force, we created an online ques-
tionnaire that we sent to Epilepsy Units around the world, 
through the chapters of the ILAE. The aims of the survey 
about the diagnostic use of SSM techniques in the context of 
suspected or possible PNES were to:
1. establish the frequency of use and nature of SSM prac-
tices around the world;
2. explore the concomitant use of (v)EEG recordings;
3. collect information about patient information and consent 
procedures;
4. record diagnostic criteria used in the evaluation of seizure 
recordings;
5. gather information on adverse effects, seizure manage-
ment, acceptability, patient feedback; and
6. learn about the personal views of clinicians in relation to 
utility, acceptability, ethical concerns, impact on patient- 
doctor relationship
By answering these questions, we hope to establish the 
extent of SSM use in clinical practice, variation in its use, and 
scope for improving clinical practice through standardization 
of SSM use, as well as attitudes of relevant stakeholders to 
SSM, in line with ILAE recommendations on clinical prac-
tice guideline development.23
2 |  METHODS
2.1 | Questionnaire development
The aims of this project and the questionnaire used for data 
collection were developed iteratively and in close collabora-
tion between a French group of epileptologists and psychi-
atrists who initiated this project and the ILAE PNES Task 
Force. Earlier drafts of the survey were tested and improved 
by the international members of the PNES Task Force to en-
sure that all questions were understandable and relevant in 
different cultural and healthcare system contexts. The ques-
tionnaire used in this survey is available as additional online 
web content (see Appendix S1). It comprised demographic 
and unit information (9 multiple- choice questions [MCQs]) 
and summary of unit- level practice (4 MCQs for those 
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working in units where SSM had never been used, 6 in units 
where it was previously, but no longer used, and 8 MCQs and 
6 binary yes/no questions where SSM is still used). For those 
working in units where SSM is used, there were additional 
sections: a summary of procedures used (19 ordinal- scale 
questions, 2 binary yes/no questions, 1 MCQ) and a survey 
of personal attitudes toward SSM (3 ordinal- scale frequency 
questions, 16 Likert- scaled opinion questions).
2.2 | Respondents
A link to an online Google Forms® version of the question-
naire (in English) was distributed by the ILAE to all of its 
national chapters with the request that chapters should dis-
seminate it further to all of their professional members at the 
start of June 2019. ILAE members were also encouraged to 
complete the survey via Epigraph, the ILAE’s regular online 
news magazine for members. In total, the ILAE currently has 
over 15 000 members (although we cannot be certain that the 
invitation email reached all members). A reminder was sent 
to all chapters with a request to pass it on to their members in 
June 2019. The survey was closed to further replies in August 
2020. For illustrative purposes, Epigraph's most recent cir-
culation was 11 164. Of these, 2139 (19.16%) were opened.
2.3 | Statistical analysis
Prior to analysis, we re- coded data for questions referring to 
institutional- level practice to account for multiple respondents 
from the same institution; where multiple respondents from the 
same institution gave different responses, we used either the 
maximum, minimum, or median of all responses from that in-
stitution, depending on the question (eg, for questions referring 
to frequency of use we took the median response, whereas for 
questions asking whether a certain technique is ever used, a sin-
gle positive answer would outweigh other negative answers). 
We summarized binary data as a proportion of respondents and 
scale data by identifying the response median (for central ten-
dency) and interquartile range IQR (for spread).
We used Friedman's two- way ANOVA by rank to assess 
differences in the frequency of use of induction and cessation 
tests with post hoc Mann- Whitney U tests using a Bonferroni- 
corrected α = 0.05 to test significance of pairwise compari-
sons if the null hypotheses of the ANOVA were rejected.
We compared attitudes toward verbal suggestion and ac-
tivation procedures against intravenous (IV) induction using 
Wilcoxon's test, with Bonferroni's correction for multiple com-
parisons. In order to gain a more fine- grained understanding of 
the responses, we carried out a number of exploratory statistical 
analyses without prespecified hypotheses (ie, differences in atti-
tudes toward SSM use depending on career background, gender, 
and age) using Kruskal- Wallis or Mann- Whitney U tests, or ordi-
nal regression, as appropriate. In order to examine whether other 
ethically contentious practices within units would affect respon-
dents' attitudes to SSM, we tested for differences in attitudes to-
ward SSM between those working in units who did or did not 
give explicitly false information to patients prior to SSM, and did 
or did not seek explicit consent for SSM (Mann- Whitney U test, 
Bonferroni adjustment for multiple comparisons).
All statistical analyses were performed in IBM SPSS 
Statistics v26.0.0.0 (IBM Corp, Armonk NY).
2.4 | Regulatory approval
The final version of the questionnaire was reviewed by the 
Psychiatry Commission and approved for dissemination via 
the national chapters by the Executive Committee of the ILAE. 
While requirements regarding ethical review for survey research 
may differ internationally, independent ethical review was not 
required for anonymous survey of members of a professional 
organization in the countries in which the leaders of this project 
were based (France and United Kingdom). According to cur-
rent best practice in the ethical review of survey research, this 
project would not require institutional ethics oversight, given 
that it did not involve vulnerable subjects and posed low risk of 
informational or psychological harm to respondents.24
3 |  RESULTS
3.1 | Participant demographics
A total of 487 respondents completed the survey. As the 
survey was distributed openly to ILAE members through 
national chapters and online publications, we are unable 
to determine the exact number of individuals invited to 
participate and as such, in the absence of a denominator 
cannot determine a response rate. Respondents came from 
411 different units across 94 countries (see Figure  1A). 
The majority of respondents were neurologists or epilep-
tologists (72.3%); the remainder comprised other clinicians 
(24.4%), other health professionals (2.2%), and research-
ers or experts by experience (see Figure 1B). 218 respond-
ents (44.8%) were female. Participant ages ranged from 
<30 years to >70 years, median category 40- 50 years old.
3.2 | Findings at unit- level
3.2.1 | Usage rates
Some form of SSM was used in 296/411 units (72.0%). The 
most commonly used SSM technique was verbal suggestion 
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alone (VS; at least sometimes used in 93.9% of those cent-
ers where any SSM is used at all), followed by activation 
procedures also capable of eliciting epileptic activity such 
as hyperventilation (HV; 84.2%) and photic stimulation 
(PS; 83.5%). See Figure 2 for frequency of use of different 
SSM techniques and Table S1 for additional information. 
Despite previously being considered a standard provoca-
tion technique,25,26 induction by nocebo techniques spe-
cifically intended to elicit PNES such as intravenous (IV) 
injection or infusion (usually saline) were used markedly 
F I G U R E  1  Geographic and career background distribution of respondents. (A) Heat map showing global distribution of respondents (B) 
career background of respondents
6 |   GRAS ET AL.
less frequently, with 73.1% of responding units reporting 
that they were never used. Other less common techniques 
reported to be in use include the following: administration 
of nocebo by different routes (oral, subcutaneous, transder-
mal; 7 respondents); auditory stimulus (eg, music, sudden 
loud noise; 3 respondents); tactile stimulus (3 respondents); 
hypnotic suggestion (2 respondents); exercise (2 respond-
ents); review of recordings of previous events; warm envi-
ronment; and tilt- table testing (all one respondent).
Frequency of use of different SSM techniques differed 
significantly (Friedman's two- way ANOVA by rank, df = 9, 
P  <  .001). Verbal suggestion, hyperventilation, and photic 
stimulation were all used more frequently than other tech-
niques, including IV saline induction (IVI). The frequency of 
VS, HV, and PS did not differ significantly in pairwise com-
parisons (Mann- Whitney U, Bonferroni- adjusted α = 0.05).
At the unit level, the most frequently cited reasons for not 
using SSM were as follows: ethical concerns (34.8%); false- 
positive risk (28.7%); damage to the doctor- patient relation-
ship (24.3%); and SSM being unnecessary (24.3%).
Not all units' respondents answered all questions relating to 
the use of suggestion to stop seizures once in progress. 242/286 
(84.6%) reported sometimes using VS, 92/277 (33.2%) IVI, 
and 38/227 (16.7%) other techniques. The frequency of use 
of different suggestive seizure cessation techniques differed 
significantly (Friedman's two- way ANOVA by rank, df = 2, 
P < .001). VS was used significantly more frequently than IVI 
or other techniques (Mann- Whitney U, Bonferroni- adjusted 
P < .001).
3.2.2 | SSM protocols
The responses suggested that 263 units (88.9%) did not have 
a written protocol for SSM. In 75 units (25.3%), SSM was 
“sometimes” performed without EEG monitoring. Patients 
were informed of the “risk of triggering a seizure” in only 
152 (51.4%) of units and gave written consent in 54 (18.2%). 
In 36 units (12.2%), patients were given explicitly false infor-
mation pre- SSM (see Figure 3).
3.2.3 | SSM risks
In 92 centers (31.1%), SSM was reported as having induced 
“false positive” epileptic seizures; in 81 centers (27.4%), 
SSM induced prolonged PNES requiring admission. Our sur-
vey did not record quantitative estimates of the frequency of 
these adverse events.
Negative comments from patients post SSM were re-
ported by responses from 93 (33.3%) of centers, whereas 213 
(81.9%) reported positive comments.
F I G U R E  2  Frequency of SSM technique use
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3.3 | Findings at individual respondent level
3.3.1 | Attitudes in units where SSM is used
A total of 342/487 (70.8%) of respondents worked in institu-
tions where SSM was at least sometimes used. Most had fa-
vorable opinions regarding the utility of SSM, either agreeing 
or strongly agreeing that SSM is useful in diagnosing PNES 
(87.2%); allows clearer diagnosis in more PNES patients 
(72.8%); permits quicker diagnosis in more PNES patients 
(76.2%); and allows shorter hospitalization for vEEG (74.0%). 
Respondents were more equivocal concerning whether SSM 
had therapeutic benefit in PNES (29.6% agree v. 32.1% disa-
gree) or improved PNES prognosis (29.2% agree v. 27.8% 
disagree). Responses are portrayed graphically in Figure 4A.
Most individual respondents using SSM felt they per-
sonally were honest in explaining the procedure to patients 
(median 8, IQR 5- 9 on a 10- point scale where 1 is actively 
misleading and 10 fully honest). 10.4% of respondents 
worked in institutions where they were encouraged to give 
explicitly false information regarding SSM to patients, and 
these respondents rated their explanations as significantly 
less honest than respondents from institutions where they 
were not so encouraged (median [IQR] rating of honesty 5 
[2.5- 8] in institutions where explicitly false information en-
couraged v 8 [5.25- 9] where it was not, P < .001).
Similarly, the majority of respondents from units where it 
is used felt comfortable with performing SSM (median 8, IQR 
5- 9, where 1 is very uncomfortable and 10 fully comfortable). 
Respondents from these units were significantly less concerned 
regarding the ethics of VS than IVI for SSM. Respondents 
felt that IVI was more ethically problematic, harmed the 
doctor- patient relationship more, harmed people with PNES 
more, and was less well- accepted by patients (Wilcoxon test; 
Bonferroni- adjusted P < .001 for all, see Figure 4B and Table 
S2 for summaries of respondents' ethical concerns).
Attitudes toward SSM did not significantly vary 
(Bonferroni- corrected α = 0.05) between respondents char-
acterized by different: career backgrounds (Kruskal- Wallis 
test); genders (Mann- Whitney U); or ages (ordinal regres-
sion, Probit link function).
Respondents who sought explicit consent to SSM were 
less likely to agree that verbal induction harmed patients with 
PNES (Mann- Whitney U, P = .001). Otherwise, attitudes did 
not vary with consent procedures. Respondents who gave ex-
plicitly false information to patients undergoing SSM did not 
significantly differ in their answers to the eight questions on 
the ethics of SSM (Figure 4B) from those who did not.
F I G U R E  3  Use of information and consent procedures
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F I G U R E  4  Respondent attitudes to SSM. (A) respondent attitudes to utility of SSM; (B) attitudes to ethics of SSM
   | 9GRAS ET AL.
3.3.2 | Attitudes in units where SSM 
is not used
A total of 142/487 (29.2%) of respondents worked in units 
where SSM is not used. The majority (78.2%) of respondents 
working in units where SSM is not used felt there were poten-
tial ethical or legal problems with SSM, most commonly that 
it violates patient trust (51.4%), damages the doctor- patient 
relationship (44.4%), or violates informed consent (43.0%, 
see Table S3 for further details).
4 |  DISCUSSION
4.1 | Use of SSM
We found that the majority (72%) of epilepsy units worldwide 
made use of SSM in some form— in the majority of cases, 
conventional activation procedures. This figure appears con-
sistent with usage rates reported in previous surveys con-
ducted in the United States.22 Noninvasive techniques (HV, 
PS, VS) and techniques which could induce epileptic activity 
as well as PNES are used more frequently than provocation 
techniques specifically intended to provoke PNES, such as 
IV nocebo administration. This is despite the fact that most 
published research on the effectiveness of SSM in diagnosis 
of PNES uses invasive nocebo administration.14 This may 
reflect recent evidence of the noninferiority of SSM without 
nocebo administration,27– 29 or it may be related to increasing 
ethical concerns of using PNES- specific invasive provoca-
tion techniques (discussed below). However, it is important 
to note that in one recent study in which noninvasive tech-
niques were used prior to nocebo injection, PNES were only 
captured in 12/27 (44%) patients after saline injection.30
There was notable heterogeneity regarding the use of 
SSM between and within responding units. The four most 
commonly employed SSM techniques (HV, PS, VS, and 
patient- specific triggers) were all deployed with a wide range 
of frequencies across units, and the majority of units would 
only utilize these in some patients and not others. This may 
reflect the previously observed lack of general consensus and 
therefore clear guidelines for the standardized employment 
of SSM within routine EEG,31 a fact underlined by the vast 
majority of responding units not having written protocols for 
SSM usage.
4.2 | Attitudes toward SSM usage
The majority of respondents from units where SSM is used 
were comfortable with its performance, though the majority 
had greater concerns regarding nocebo induction than VS. 
These concerns related more to the ethics of nocebo induction 
than potential harms, with many respondents agreeing that 
provocative techniques may either be ethically problematic 
(unfortunately the survey design of our research prevented 
interrogating this further) or might harm the doctor- patient re-
lationship. There is some evidence that SSM protocols with-
out invasive techniques such as IV nocebo are noninferior to 
invasive ones (ie, statistically as likely to be diagnostically 
helpful).27 However, since several conventional noninvasive 
techniques may also reduce the threshold for epileptic sei-
zures (especially hyperventilation and photic stimulation), 
there may remain contexts where the risks of an epileptic 
seizure are felt sufficiently high to make alternative methods 
of nocebo induction preferable (one such context which has 
been cited is the late stage of pregnancy).32 If nocebo induc-
tion is used, it will be important to mitigate ethical concerns. 
This could be done by using disclosure and informed con-
sent, along with protocols that honestly inform patients of 
the placebo nature of the induction technique and of the pos-
sibility that PNES may occur. While concerns persist that this 
may reduce the diagnostic yield, published research suggests 
that explicit, informative protocols do not decrease (and may 
increase) the diagnostic yield of SSM.28,30,33,34 A first step 
in addressing this issue would be to stop (or minimize) de-
liberately misinforming patients, reported in 12.2% of units. 
Explicit guidelines on ethical use of SSM would empower 
practitioners to employ SSM in a more responsible fashion31 
and would not be expected to reduce diagnostic yield.14
4.3 | Limitations
Several limitations to this study should be noted. It is dif-
ficult to ascertain how representative our sample of respond-
ents is of the community of epilepsy professionals. Despite 
many responses from a wide range of countries spanning six 
continents, given the manner in which the survey was cir-
culated (with ILAE national chapters being responsible for 
dissemination to their own members), we cannot accurately 
determine a response rate. The survey was only available 
in English, which may bias the results toward those regions 
where English is a main spoken or professional language. Not 
all health workers involved in diagnosis of PNES— including 
SSM usage— will be ILAE members, introducing a further 
potential source of selection bias. Differential response rates 
to survey invitations between specialties may unduly weight 
our responses further toward those from neurologists.35
The use of different questionnaires for respondents work-
ing in units where SSM is or is not routinely used precluded a 
direct comparison of attitudes toward SSM between respon-
dents working in these different settings. This would be a 
question of interest in attempting to design protocols for SSM 
usage, to ensure the concerns of those who do not presently 
make use of such techniques are addressed appropriately.
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While the survey documented reports of adverse effects of 
SSM (such as “false positive” epileptic seizures or prolonged 
PNES), we did not ask respondents to report frequency of 
these events, so cannot reliably conclude how often these 
commonly cited adverse effects of SSM occur. Such figures 
would clearly be of use in appraising benefits and risks of 
SSM and seeking fully informed consent from patients.
The use of a survey design itself introduces some im-
portant limitations. Forced- response choices limit fine- 
grained analysis of our respondents' attitudes toward SSM 
usage, which would more appropriately be interrogated 
with qualitative research.36 Such research would be a valu-
able complement to our results; however, the present sur-
vey permits a far larger sample than could be achieved in 
such a study and thus is able to present a more representa-
tive picture of international clinicians’ use of and attitudes 
toward SSM.37
Lastly, our survey was addressed to healthcare workers 
and not patients with seizure disorders, and thus, few con-
clusions can be drawn about the acceptability and tolerability 
of SSM to patients. However, our respondents' reported low 
rates of dissatisfaction with SSM that are supported by pre-
vious research suggesting that patients generally find SSM 
acceptable and comfortable and are willing to undergo them 
when their use is explained properly.38
5 |  CONCLUSION
Suggestive seizure manipulation, in the forms of conven-
tional EEG activation procedures (hyperventilation and 
photic stimulation) and verbal suggestion, is a widespread 
technique used in the diagnosis of PNES, with proven value 
in increasing the diagnostic yield of (v)EEG. However, the 
employment of SSM is not at all standardized within and be-
tween epilepsy units, potentially reducing the efficiency and 
reliability of these investigations. Furthermore, though not 
widespread, more invasive SSM provocation techniques spe-
cifically intended to provoke PNES (eg, iv saline infusion) 
are still sometimes used in a deceptive or otherwise ethically 
suspect fashion.
The findings of this ILAE survey underscore the need for 
a standardized approach to the use of SSM in the diagnosis of 
PNES. While proposals for best practice exist,31 there are as 
of yet no internationally accepted standardized guidelines, and 
many units lack even internal protocols for SSM. This study 
should stimulate different EEG laboratory units worldwide 
to share their experience and start discussion about standard-
ization of SSM procedures for making accurate diagnosis of 
PNES. Further research involving a more nuanced qualitative 
approach and capturing the views of patients and clinicians 
would be useful to inform the development of guidelines for the 
safe and ethical use of SSM. In the interim, departments could 
use recent summaries of evidence surrounding use of SSM,14 
and previous proposals for best practice guidance on its use,31 
as templates for developing local protocols to ensure safe, eth-
ical, and consistent use of this technique in clinical practice.
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